1) Understand the optimal window for steroids use in acute alcohol-associated hepatitis.
2) Recognize the potential impact of national policy changes on alcohol use.
3) Identify the components and benefits of the integrated care approach to the management of patients with advanced alcohol-associated liver disease.
4) Address the controversies surrounding liver transplantation for alcohol-associated liver disease.
Nazia Selzner (Canada)
to view this session in the congress program.